Pharmarise Holdings: Notice regarding the review of the medium-term management plan
Pharmarise Holdings: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending May 31, 2020 [Japanese GAAP] (consolidated)
Pharmarise Holdings: Notice regarding differences between consolidated earnings forecasts and actual values for the 2nd quarter (interim period) of the fiscal year ending May 31, 2020, and revisions to the full-year consolidated earnings forecast
Pharmarise Holdings: Notice regarding the setting of materiality KPIs
Pharmarise Holdings: Treasury stock purchase status report (based on Act Section 24-6 (1))
Pharmarise Holdings: Notice regarding the status of treasury stock repurchases
Pharmarise Holdings: About some of today's reports
Pharmarise Holdings: Legal post-facto disclosure documents (company split) (NEXT PH Co., Ltd.)
Pharmarise Holdings: Notice regarding the opening of a new pharmacy
Pharmarise Holdings: Notice regarding pharmacy business transfer
Pharmarise Holdings: Notice Concerning Borrowing of Funds
Pharmarise Holdings: Notice regarding the status of treasury stock repurchases
Pharmarise Holdings: Treasury stock purchase status report (based on Act Section 24-6 (1))
Pharmarise Holdings: Legal Advance Disclosure Documents (Company Split) (NEXT PH Co., Ltd.)
Pharmarise Holdings: Extraordinary Report
Pharmarise Holdings: Notice regarding the company split (simple absorption split) into a subsidiary due to the transfer of part of the business from the Kanichi Shoten Group
Pharmarise Holdings: Notice regarding the details of shareholder benefits
Pharmarise Holdings: [Delayed]Consolidated Financial Results for the First Three Months of the Fiscal Year Ending May 31, 2025 (Japan GAAP)
Pharmarise Holdings: Notice regarding the status of the company's stock acquisition
Pharmarise Holdings: Report on the Status of Purchases of Treasury Stock by the Company (Based on Article 24-6, Paragraph 1 of the Law)
No Data